Beung‐Chul Ahn

947 total citations
38 papers, 621 citations indexed

About

Beung‐Chul Ahn is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Beung‐Chul Ahn has authored 38 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 28 papers in Pulmonary and Respiratory Medicine and 6 papers in Cancer Research. Recurrent topics in Beung‐Chul Ahn's work include Lung Cancer Treatments and Mutations (24 papers), Lung Cancer Research Studies (14 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Beung‐Chul Ahn is often cited by papers focused on Lung Cancer Treatments and Mutations (24 papers), Lung Cancer Research Studies (14 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Beung‐Chul Ahn collaborates with scholars based in South Korea, United States and Sweden. Beung‐Chul Ahn's co-authors include Min Hee Hong, Byoung Chul Cho, Hye Ryun Kim, Hyo Sup Shim, Kyoung‐Ho Pyo, Hong In Yoon, Sung Yong Park, Seong Jin Choi, Eui‐Cheol Shin and Y. Kim and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Beung‐Chul Ahn

34 papers receiving 618 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Beung‐Chul Ahn South Korea	12	497	366	106	106	81	38	621
Giulia Mazzaschi Italy	11	444 0.9×	254 0.7×	130 1.2×	166 1.6×	96 1.2×	54	634
J.M. Sánchez-Torres Spain	13	614 1.2×	428 1.2×	150 1.4×	99 0.9×	104 1.3×	21	772
Iveta Kudaba Latvia	14	635 1.3×	490 1.3×	61 0.6×	75 0.7×	72 0.9×	24	750
Maria Bassanelli Italy	10	419 0.8×	326 0.9×	99 0.9×	57 0.5×	68 0.8×	23	547
Angel Qin United States	12	343 0.7×	201 0.5×	178 1.7×	94 0.9×	122 1.5×	33	561
Gen Lin China	12	309 0.6×	251 0.7×	163 1.5×	120 1.1×	127 1.6×	64	537
M-J. Ahn South Korea	14	517 1.0×	394 1.1×	118 1.1×	105 1.0×	93 1.1×	68	622
Jun Sugisaka Japan	8	602 1.2×	287 0.8×	82 0.8×	109 1.0×	36 0.4×	20	680
Ashley Kowalewski United States	5	677 1.4×	331 0.9×	77 0.7×	225 2.1×	140 1.7×	5	768
Fanrong Zhang China	13	391 0.8×	232 0.6×	96 0.9×	77 0.7×	138 1.7×	31	546

Countries citing papers authored by Beung‐Chul Ahn

Since Specialization

Citations

This map shows the geographic impact of Beung‐Chul Ahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beung‐Chul Ahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beung‐Chul Ahn more than expected).

Fields of papers citing papers by Beung‐Chul Ahn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beung‐Chul Ahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beung‐Chul Ahn. The network helps show where Beung‐Chul Ahn may publish in the future.

Co-authorship network of co-authors of Beung‐Chul Ahn

This figure shows the co-authorship network connecting the top 25 collaborators of Beung‐Chul Ahn. A scholar is included among the top collaborators of Beung‐Chul Ahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beung‐Chul Ahn. Beung‐Chul Ahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yu, Namhee, Beung‐Chul Ahn, Youngjoo Lee, et al.. (2025). Longitudinal pharmacogenomic analysis of refractory lung cancer to identify therapeutic candidates for epidermal growth factor receptor–tyrosine kinase inhibitor resistance subclones. Experimental & Molecular Medicine. 57(7). 1567–1578.

Kim, Su‐Hyun, Beung‐Chul Ahn, Dong-Eun Lee, et al.. (2024). Blood Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Promising Screening Biomarkers for Brain Metastases in Patients with Lung Cancer. International Journal of Molecular Sciences. 25(12). 6397–6397. 3 indexed citations

Lee, Youngjoo, Bo Song, Namhee Yu, et al.. (2024). Drug Response of Patient-Derived Lung Cancer Cells Predicts Clinical Outcomes of Targeted Therapy. Cancers. 16(4). 778–778. 3 indexed citations

Ahn, Beung‐Chul, et al.. (2024). Complete Remission of Dural-Based Leptomeningeal Metastasis in Patient With Non-Small Cell Lung Cancer by Osimertinib. Brain Tumor Research and Treatment. 12(4). 245–245.

Moon, Sung Ho, Youngjoo Lee, Beung‐Chul Ahn, et al.. (2023). Treatment Outcomes of Proton Beam Therapy for Esophageal Squamous Cell Carcinoma at a Single Institute. Cancers. 15(23). 5524–5524. 1 indexed citations

Ahn, Beung‐Chul, Charny Park, Sang-Jin Lee, et al.. (2023). Nivolumab after Induction Chemotherapy in Previously Treated Non-Small-Cell Lung Cancer Patients with Low PD-L1 Expression. Cancers. 15(18). 4460–4460. 1 indexed citations

Kim, Hyunwook, Beung‐Chul Ahn, Jiyun Lee, et al.. (2023). Lazertinib in Pretreated EGFR T790M-Mutated Advanced Non-Small Cell Lung Cancer: A Real-World Multicenter Study. SSRN Electronic Journal.

Ahn, Beung‐Chul, Seo-Young Lee, Jiyun Lee, et al.. (2023). Clinical utility of a plasma-based comprehensive genomic profiling test in patients with non-small cell lung cancer in Korea. Cancer Treatment and Research Communications. 36. 100715–100715. 1 indexed citations

Ahn, Beung‐Chul, Charny Park, Jong Mog Lee, et al.. (2023). Tumor Microenvironment Modulation by Neoadjuvant Erlotinib Therapy and Its Clinical Impact on Operable EGFR-Mutant Non–Small Cell Lung Cancer. Cancer Research and Treatment. 56(1). 70–80. 1 indexed citations

10.

Yu, Namhee, Youngjoo Lee, Bo Song, et al.. (2023). Patient-derived cell-based pharmacogenomic assessment to unveil underlying resistance mechanisms and novel therapeutics for advanced lung cancer. Journal of Experimental & Clinical Cancer Research. 42(1). 37–37. 13 indexed citations

11.

Kim, Hyunwook, Beung‐Chul Ahn, Jiyun Lee, et al.. (2023). Lazertinib in pretreated EGFR T790M-mutated advanced non-small cell lung cancer: A real-world multicenter study. Lung Cancer. 180. 107213–107213. 3 indexed citations

12.

Ahn, Beung‐Chul, et al.. (2022). Real World Characteristics and Clinical Outcomes of HER2-Mutant Non–Small Cell Lung Cancer Patients Detected by Next-Generation Sequencing. Cancer Research and Treatment. 55(2). 488–497. 16 indexed citations

13.

Lee, Seo-Young, Hyo Sup Shim, Beung‐Chul Ahn, et al.. (2021). Efficacy and safety of atezolizumab, in combination with etoposide and carboplatin regimen, in the first-line treatment of extensive-stage small-cell lung cancer: a single-center experience. Cancer Immunology Immunotherapy. 71(5). 1093–1101. 29 indexed citations

14.

Kim, Chang Gon, Min Hee Hong, Kyung Hwan Kim, et al.. (2020). Dynamic changes in circulating PD-1+CD8+ T lymphocytes for predicting treatment response to PD-1 blockade in patients with non-small-cell lung cancer. European Journal of Cancer. 143. 113–126. 35 indexed citations

15.

Hong, Min Hee, Hye Ryun Kim, Beung‐Chul Ahn, et al.. (2019). Real-World Analysis of the Efficacy of Rebiopsy andEGFRMutation Test of Tissue and Plasma Samples in Drug-Resistant Non-Small Cell Lung Cancer. Yonsei Medical Journal. 60(6). 525–525. 17 indexed citations

16.

Kim, Chun‐Gon, Kyoung‐Ho Kim, Kyoung‐Ho Pyo, et al.. (2019). Hyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancer. Annals of Oncology. 30(7). 1104–1113. 201 indexed citations

17.

Kim, Seok‐Young, Donghwi Kim, Mi Ran Yun, et al.. (2019). Patient-Derived Cells to Guide Targeted Therapy for Advanced Lung Adenocarcinoma. Scientific Reports. 9(1). 19909–19909. 27 indexed citations

18.

Ahn, Beung‐Chul, Kyoung‐Ho Pyo, Dongmin Jung, et al.. (2019). Comprehensive analysis of the characteristics and treatment outcomes of patients with non-small cell lung cancer treated with anti-PD-1 therapy in real-world practice. Journal of Cancer Research and Clinical Oncology. 145(6). 1613–1623. 74 indexed citations

19.

Ahn, Beung‐Chul, Kyoung‐Ho Pyo, Dongmin Jung, et al.. (2019). A machine learning based prediction model of anti-PD-1 therapy response using noninvasive clinical information and blood markers of lung cancer patients.. Journal of Clinical Oncology. 37(15_suppl). e14138–e14138. 1 indexed citations

20.

Park, Sehhoon, Beung‐Chul Ahn, Sung Won Lim, et al.. (2018). Characteristics and Outcome of ROS1-Positive Non–Small Cell Lung Cancer Patients in Routine Clinical Practice. Journal of Thoracic Oncology. 13(9). 1373–1382. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact